home / stock / rmd / rmd articles

RMD Articles, ResMed Inc. - From 02/01/24

Stock Information
Company Name: ResMed Inc.
Stock Symbol: RMD
Market: NYSE
Website: resmed.com
Menu
RMD RMD Quote RMD Short RMD News RMD Articles RMD Message Board
Get RMD Alerts

News, Short Squeeze, Breakout and More Instantly...
Here's How Much You Would Have Made Owning ResMed Stock In The Last 15 Years | Benzinga

ResMed (NYSE:RMD) has outperformed the market over the past 15 years by 3.62% on an annualized basis producing an average annual return of 15.8%. C...
AT&T To Rally Around 44%? Here Are 10 Top Analyst Forecasts For Thursday | Benzinga

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...

FDA Identifies ResMed's Recall Of Certain Ventilator Device Masks With Magnets As Most Serious | Benzinga

Thursday, ResMed Ltd (NYSE:RMD) said it is recalling some of its Continuous Positive Airway Pressure (CPAP) masks with magnets ...

If You Invested $100 In This Stock 15 Years Ago, You Would Have $900 Today | Benzinga

ResMed (NYSE:RMD) has outperformed the market over the past 15 years by 3.76% on an annualized basis producing an average annual return of 15.97%. ...
ResMed Announces Participation in the 42nd Annual J.P. Morgan Healthcare Conference | Benzinga

SAN DIEGO, Dec. 27, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE:RMD, ASX: RMD)) today announced Mick Farrell, chief executive officer and chair of the...

$1000 Invested In ResMed 15 Years Ago Would Be Worth This Much Today | Benzinga

ResMed (NYSE:RMD) has outperformed the market over the past 15 years by 4.34% on an annualized basis producing an average annual return of 16.13%. ...

If You Invested $1000 In This Stock 20 Years Ago, You Would Have $17,000 Today | Benzinga

ResMed (NYSE:RMD) has outperformed the market over the past 20 years by 7.47% on an annualized basis producing an average annual return of 15.05%. ...
ResMed Secures Significant Victory in Patent Fight Against New York University | Benzinga

SAN DIEGO, Dec. 11, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE:RMD, ASX: RMD)) announced that it has secured a significant victory after the United S...

Senator's Bearish Tesla Bet Under Scrutiny As He Buys Put Options Ahead Of Elon Musk-Led Company's Q3 Results That Set Stock Slide In Motion | Benzinga

Tesla, Inc. (NASDAQ:TSLA) shares have been going through a lean phase and the modest recovery seen has been in fits-and-starts. Against this backdr...

ResMed Adopts New Operating Model to Accelerate Long-term Growth | Benzinga

Justin Leong appointed Chief Product Officer, effective immediately. Katrin Pucknat appointed Chief Marketing Officer, effective immediately. Mik...
Previous 10 Next 10